메뉴 건너뛰기




Volumn 23, Issue 24, 2013, Pages 6829-6833

Novel Mps1 kinase inhibitors: From purine to pyrrolopyrimidine and quinazoline leads

Author keywords

Cancer; Conformational restriction; Mps1; Protein kinase inhibitors; Purines; Pyrrolopyrimidines; Quinazoline; Scaffold hopping; Structure based design; TTK

Indexed keywords

PROTEIN KINASE; PROTEIN KINASE INHIBITOR; PROTEIN MPS1; PURINE DERIVATIVE; PYRROLOPYRIMIDINE DERIVATIVE; QUINAZOLINE DERIVATIVE; UNCLASSIFIED DRUG;

EID: 84888880276     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2013.10.008     Document Type: Article
Times cited : (14)

References (17)
  • 12
    • 31544450787 scopus 로고    scopus 로고
    • Crystal structure of Mps1 complex with a small molecule inhibitor (PDB ID, Ref. 6) solved with resolution 2.60 Å was used as a target for docking. Docking model of Mps1 complex with compound 1 was further refined using Schrodinger induced fit docking protocol
    • Crystal structure of Mps1 complex with a small molecule inhibitor (PDB ID 3H9F, Ref. 6) solved with resolution 2.60 Å was used as a target for docking. Docking model of Mps1 complex with compound 1 was further refined using Schrodinger induced fit docking protocol: W. Sherman, T. Day, M.P. Jacobson, R.A. Friesner, and R. Farid J. Med. Chem. 49 2006 534
    • (2006) J. Med. Chem. , vol.49 , pp. 534
    • Sherman, W.1    Day, T.2    Jacobson, M.P.3    Friesner, R.A.4    Farid, R.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.